Click for best price
Antiviral Drug Resistance Market Size, Share 2024
Antiviral drug resistance refers to decreased susceptibility towards a drug which occurs due to changes in viral genotypes. During instances of antiviral resistance, the drugs have either lost their effectiveness or have been diminished against the virus to be targeted. Antiviral drug resistance is a rising concern among the immune-compromised patients.
This report aims to provide a comprehensive presentation of the global market for Antiviral Drug Resistance, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiviral Drug Resistance. This report contains market size and forecasts of Antiviral Drug Resistance in global, including the following market information:
Global Antiviral Drug Resistance Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
The global Antiviral Drug Resistance market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Immunodiagnostics Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Antiviral Drug Resistance include AccuBioTech Co., Ltd., ACON Laboratories, Inc., Siemens AG, BioMerieux SA, Bio-Rad Laboratories, Inc., Danaher, Abbott, BD and F. Hoffmann-La Roche Ltd., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Antiviral Drug Resistance companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antiviral Drug Resistance Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Antiviral Drug Resistance Market Segment Percentages, by Type, 2023 (%)
Immunodiagnostics
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Sanger Sequencing
Other Technologies
Global Antiviral Drug Resistance Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Antiviral Drug Resistance Market Segment Percentages, by Application, 2023 (%)
Hospitals & Clinics
Pathology or Diagnostic Laboratories
Research Institutes
Others
Global Antiviral Drug Resistance Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Antiviral Drug Resistance Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antiviral Drug Resistance revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Antiviral Drug Resistance revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
AccuBioTech Co., Ltd.
ACON Laboratories, Inc.
Siemens AG
BioMerieux SA
Bio-Rad Laboratories, Inc.
Danaher
Abbott
BD
F. Hoffmann-La Roche Ltd.
Trinity Biotech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antiviral Drug Resistance, market overview.
Chapter 2: Global Antiviral Drug Resistance market size in revenue.
Chapter 3: Detailed analysis of Antiviral Drug Resistance company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antiviral Drug Resistance in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Antiviral Drug Resistance Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
63 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Antiviral Drug Resistance Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antiviral Drug Resistance Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antiviral Drug Resistance Overall Market Size
2.1 Global Antiviral Drug Resistance Market Size: 2023 VS 2030
2.2 Global Antiviral Drug Resistance Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antiviral Drug Resistance Players in Global Market
3.2 Top Global Antiviral Drug Resistance Companies Ranked by Revenue
3.3 Global Antiviral Drug Resistance Revenue by Companies
3.4 Top 3 and Top 5 Antiviral Drug Resistance Companies in Global Market, by Revenue in 2023
3.5 Global Companies Antiviral Drug Resistance Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antiviral Drug Resistance Players in Global Market
3.6.1 List of Global Tier 1 Antiviral Drug Resistance Companies
3.6.2 List of Global Tier 2 and Tier 3 Antiviral Drug Resistance Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Antiviral Drug Resistance Market Size Markets, 2023 & 2030
4.1.2 Immunodiagnostics
4.1.3 Polymerase Chain Reaction (PCR)
4.1.4 Next Generation Sequencing (NGS)
4.1.5 Sanger Sequencing
4.1.6 Other Technologies
4.2 By Type - Global Antiviral Drug Resistance Revenue & Forecasts
4.2.1 By Type - Global Antiviral Drug Resistance Revenue, 2019-2024
4.2.2 By Type - Global Antiviral Drug Resistance Revenue, 2025-2030
4.2.3 By Type - Global Antiviral Drug Resistance Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Antiviral Drug Resistance Market Size, 2023 & 2030
5.1.2 Hospitals & Clinics
5.1.3 Pathology or Diagnostic Laboratories
5.1.4 Research Institutes
5.1.5 Others
5.2 By Application - Global Antiviral Drug Resistance Revenue & Forecasts
5.2.1 By Application - Global Antiviral Drug Resistance Revenue, 2019-2024
5.2.2 By Application - Global Antiviral Drug Resistance Revenue, 2025-2030
5.2.3 By Application - Global Antiviral Drug Resistance Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Antiviral Drug Resistance Market Size, 2023 & 2030
6.2 By Region - Global Antiviral Drug Resistance Revenue & Forecasts
6.2.1 By Region - Global Antiviral Drug Resistance Revenue, 2019-2024
6.2.2 By Region - Global Antiviral Drug Resistance Revenue, 2025-2030
6.2.3 By Region - Global Antiviral Drug Resistance Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Antiviral Drug Resistance Revenue, 2019-2030
6.3.2 US Antiviral Drug Resistance Market Size, 2019-2030
6.3.3 Canada Antiviral Drug Resistance Market Size, 2019-2030
6.3.4 Mexico Antiviral Drug Resistance Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Antiviral Drug Resistance Revenue, 2019-2030
6.4.2 Germany Antiviral Drug Resistance Market Size, 2019-2030
6.4.3 France Antiviral Drug Resistance Market Size, 2019-2030
6.4.4 U.K. Antiviral Drug Resistance Market Size, 2019-2030
6.4.5 Italy Antiviral Drug Resistance Market Size, 2019-2030
6.4.6 Russia Antiviral Drug Resistance Market Size, 2019-2030
6.4.7 Nordic Countries Antiviral Drug Resistance Market Size, 2019-2030
6.4.8 Benelux Antiviral Drug Resistance Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Antiviral Drug Resistance Revenue, 2019-2030
6.5.2 China Antiviral Drug Resistance Market Size, 2019-2030
6.5.3 Japan Antiviral Drug Resistance Market Size, 2019-2030
6.5.4 South Korea Antiviral Drug Resistance Market Size, 2019-2030
6.5.5 Southeast Asia Antiviral Drug Resistance Market Size, 2019-2030
6.5.6 India Antiviral Drug Resistance Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Antiviral Drug Resistance Revenue, 2019-2030
6.6.2 Brazil Antiviral Drug Resistance Market Size, 2019-2030
6.6.3 Argentina Antiviral Drug Resistance Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Antiviral Drug Resistance Revenue, 2019-2030
6.7.2 Turkey Antiviral Drug Resistance Market Size, 2019-2030
6.7.3 Israel Antiviral Drug Resistance Market Size, 2019-2030
6.7.4 Saudi Arabia Antiviral Drug Resistance Market Size, 2019-2030
6.7.5 UAE Antiviral Drug Resistance Market Size, 2019-2030
7 Antiviral Drug Resistance Companies Profiles
7.1 AccuBioTech Co., Ltd.
7.1.1 AccuBioTech Co., Ltd. Company Summary
7.1.2 AccuBioTech Co., Ltd. Business Overview
7.1.3 AccuBioTech Co., Ltd. Antiviral Drug Resistance Major Product Offerings
7.1.4 AccuBioTech Co., Ltd. Antiviral Drug Resistance Revenue in Global Market (2019-2024)
7.1.5 AccuBioTech Co., Ltd. Key News & Latest Developments
7.2 ACON Laboratories, Inc.
7.2.1 ACON Laboratories, Inc. Company Summary
7.2.2 ACON Laboratories, Inc. Business Overview
7.2.3 ACON Laboratories, Inc. Antiviral Drug Resistance Major Product Offerings
7.2.4 ACON Laboratories, Inc. Antiviral Drug Resistance Revenue in Global Market (2019-2024)
7.2.5 ACON Laboratories, Inc. Key News & Latest Developments
7.3 Siemens AG
7.3.1 Siemens AG Company Summary
7.3.2 Siemens AG Business Overview
7.3.3 Siemens AG Antiviral Drug Resistance Major Product Offerings
7.3.4 Siemens AG Antiviral Drug Resistance Revenue in Global Market (2019-2024)
7.3.5 Siemens AG Key News & Latest Developments
7.4 BioMerieux SA
7.4.1 BioMerieux SA Company Summary
7.4.2 BioMerieux SA Business Overview
7.4.3 BioMerieux SA Antiviral Drug Resistance Major Product Offerings
7.4.4 BioMerieux SA Antiviral Drug Resistance Revenue in Global Market (2019-2024)
7.4.5 BioMerieux SA Key News & Latest Developments
7.5 Bio-Rad Laboratories, Inc.
7.5.1 Bio-Rad Laboratories, Inc. Company Summary
7.5.2 Bio-Rad Laboratories, Inc. Business Overview
7.5.3 Bio-Rad Laboratories, Inc. Antiviral Drug Resistance Major Product Offerings
7.5.4 Bio-Rad Laboratories, Inc. Antiviral Drug Resistance Revenue in Global Market (2019-2024)
7.5.5 Bio-Rad Laboratories, Inc. Key News & Latest Developments
7.6 Danaher
7.6.1 Danaher Company Summary
7.6.2 Danaher Business Overview
7.6.3 Danaher Antiviral Drug Resistance Major Product Offerings
7.6.4 Danaher Antiviral Drug Resistance Revenue in Global Market (2019-2024)
7.6.5 Danaher Key News & Latest Developments
7.7 Abbott
7.7.1 Abbott Company Summary
7.7.2 Abbott Business Overview
7.7.3 Abbott Antiviral Drug Resistance Major Product Offerings
7.7.4 Abbott Antiviral Drug Resistance Revenue in Global Market (2019-2024)
7.7.5 Abbott Key News & Latest Developments
7.8 BD
7.8.1 BD Company Summary
7.8.2 BD Business Overview
7.8.3 BD Antiviral Drug Resistance Major Product Offerings
7.8.4 BD Antiviral Drug Resistance Revenue in Global Market (2019-2024)
7.8.5 BD Key News & Latest Developments
7.9 F. Hoffmann-La Roche Ltd.
7.9.1 F. Hoffmann-La Roche Ltd. Company Summary
7.9.2 F. Hoffmann-La Roche Ltd. Business Overview
7.9.3 F. Hoffmann-La Roche Ltd. Antiviral Drug Resistance Major Product Offerings
7.9.4 F. Hoffmann-La Roche Ltd. Antiviral Drug Resistance Revenue in Global Market (2019-2024)
7.9.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.10 Trinity Biotech
7.10.1 Trinity Biotech Company Summary
7.10.2 Trinity Biotech Business Overview
7.10.3 Trinity Biotech Antiviral Drug Resistance Major Product Offerings
7.10.4 Trinity Biotech Antiviral Drug Resistance Revenue in Global Market (2019-2024)
7.10.5 Trinity Biotech Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Antiviral Drug Resistance Market Opportunities & Trends in Global Market
Table 2. Antiviral Drug Resistance Market Drivers in Global Market
Table 3. Antiviral Drug Resistance Market Restraints in Global Market
Table 4. Key Players of Antiviral Drug Resistance in Global Market
Table 5. Top Antiviral Drug Resistance Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Antiviral Drug Resistance Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Antiviral Drug Resistance Revenue Share by Companies, 2019-2024
Table 8. Global Companies Antiviral Drug Resistance Product Type
Table 9. List of Global Tier 1 Antiviral Drug Resistance Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antiviral Drug Resistance Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Antiviral Drug Resistance Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Antiviral Drug Resistance Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Antiviral Drug Resistance Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Antiviral Drug Resistance Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Antiviral Drug Resistance Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Antiviral Drug Resistance Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Antiviral Drug Resistance Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Antiviral Drug Resistance Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Antiviral Drug Resistance Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Antiviral Drug Resistance Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Antiviral Drug Resistance Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Antiviral Drug Resistance Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Antiviral Drug Resistance Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Antiviral Drug Resistance Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Antiviral Drug Resistance Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Antiviral Drug Resistance Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Antiviral Drug Resistance Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Antiviral Drug Resistance Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Antiviral Drug Resistance Revenue, (US$, Mn), 2025-2030
Table 30. AccuBioTech Co., Ltd. Company Summary
Table 31. AccuBioTech Co., Ltd. Antiviral Drug Resistance Product Offerings
Table 32. AccuBioTech Co., Ltd. Antiviral Drug Resistance Revenue (US$, Mn) & (2019-2024)
Table 33. AccuBioTech Co., Ltd. Key News & Latest Developments
Table 34. ACON Laboratories, Inc. Company Summary
Table 35. ACON Laboratories, Inc. Antiviral Drug Resistance Product Offerings
Table 36. ACON Laboratories, Inc. Antiviral Drug Resistance Revenue (US$, Mn) & (2019-2024)
Table 37. ACON Laboratories, Inc. Key News & Latest Developments
Table 38. Siemens AG Company Summary
Table 39. Siemens AG Antiviral Drug Resistance Product Offerings
Table 40. Siemens AG Antiviral Drug Resistance Revenue (US$, Mn) & (2019-2024)
Table 41. Siemens AG Key News & Latest Developments
Table 42. BioMerieux SA Company Summary
Table 43. BioMerieux SA Antiviral Drug Resistance Product Offerings
Table 44. BioMerieux SA Antiviral Drug Resistance Revenue (US$, Mn) & (2019-2024)
Table 45. BioMerieux SA Key News & Latest Developments
Table 46. Bio-Rad Laboratories, Inc. Company Summary
Table 47. Bio-Rad Laboratories, Inc. Antiviral Drug Resistance Product Offerings
Table 48. Bio-Rad Laboratories, Inc. Antiviral Drug Resistance Revenue (US$, Mn) & (2019-2024)
Table 49. Bio-Rad Laboratories, Inc. Key News & Latest Developments
Table 50. Danaher Company Summary
Table 51. Danaher Antiviral Drug Resistance Product Offerings
Table 52. Danaher Antiviral Drug Resistance Revenue (US$, Mn) & (2019-2024)
Table 53. Danaher Key News & Latest Developments
Table 54. Abbott Company Summary
Table 55. Abbott Antiviral Drug Resistance Product Offerings
Table 56. Abbott Antiviral Drug Resistance Revenue (US$, Mn) & (2019-2024)
Table 57. Abbott Key News & Latest Developments
Table 58. BD Company Summary
Table 59. BD Antiviral Drug Resistance Product Offerings
Table 60. BD Antiviral Drug Resistance Revenue (US$, Mn) & (2019-2024)
Table 61. BD Key News & Latest Developments
Table 62. F. Hoffmann-La Roche Ltd. Company Summary
Table 63. F. Hoffmann-La Roche Ltd. Antiviral Drug Resistance Product Offerings
Table 64. F. Hoffmann-La Roche Ltd. Antiviral Drug Resistance Revenue (US$, Mn) & (2019-2024)
Table 65. F. Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 66. Trinity Biotech Company Summary
Table 67. Trinity Biotech Antiviral Drug Resistance Product Offerings
Table 68. Trinity Biotech Antiviral Drug Resistance Revenue (US$, Mn) & (2019-2024)
Table 69. Trinity Biotech Key News & Latest Developments
List of Figures
Figure 1. Antiviral Drug Resistance Segment by Type in 2023
Figure 2. Antiviral Drug Resistance Segment by Application in 2023
Figure 3. Global Antiviral Drug Resistance Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Antiviral Drug Resistance Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Antiviral Drug Resistance Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antiviral Drug Resistance Revenue in 2023
Figure 8. By Type - Global Antiviral Drug Resistance Revenue Market Share, 2019-2030
Figure 9. By Application - Global Antiviral Drug Resistance Revenue Market Share, 2019-2030
Figure 10. By Type - Global Antiviral Drug Resistance Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Antiviral Drug Resistance Revenue Market Share, 2019-2030
Figure 12. By Application - Global Antiviral Drug Resistance Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Antiviral Drug Resistance Revenue Market Share, 2019-2030
Figure 14. By Region - Global Antiviral Drug Resistance Revenue Market Share, 2019-2030
Figure 15. By Country - North America Antiviral Drug Resistance Revenue Market Share, 2019-2030
Figure 16. US Antiviral Drug Resistance Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Antiviral Drug Resistance Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Antiviral Drug Resistance Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Antiviral Drug Resistance Revenue Market Share, 2019-2030
Figure 20. Germany Antiviral Drug Resistance Revenue, (US$, Mn), 2019-2030
Figure 21. France Antiviral Drug Resistance Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Antiviral Drug Resistance Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Antiviral Drug Resistance Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Antiviral Drug Resistance Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Antiviral Drug Resistance Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Antiviral Drug Resistance Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Antiviral Drug Resistance Revenue Market Share, 2019-2030
Figure 28. China Antiviral Drug Resistance Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Antiviral Drug Resistance Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Antiviral Drug Resistance Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Antiviral Drug Resistance Revenue, (US$, Mn), 2019-2030
Figure 32. India Antiviral Drug Resistance Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Antiviral Drug Resistance Revenue Market Share, 2019-2030
Figure 34. Brazil Antiviral Drug Resistance Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Antiviral Drug Resistance Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Antiviral Drug Resistance Revenue Market Share, 2019-2030
Figure 37. Turkey Antiviral Drug Resistance Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Antiviral Drug Resistance Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Antiviral Drug Resistance Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Antiviral Drug Resistance Revenue, (US$, Mn), 2019-2030
Figure 41. AccuBioTech Co., Ltd. Antiviral Drug Resistance Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. ACON Laboratories, Inc. Antiviral Drug Resistance Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Siemens AG Antiviral Drug Resistance Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. BioMerieux SA Antiviral Drug Resistance Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Bio-Rad Laboratories, Inc. Antiviral Drug Resistance Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Danaher Antiviral Drug Resistance Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Abbott Antiviral Drug Resistance Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. BD Antiviral Drug Resistance Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. F. Hoffmann-La Roche Ltd. Antiviral Drug Resistance Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Trinity Biotech Antiviral Drug Resistance Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
